Experimental Drug Provides Lasting Relief For Bleeding Condition

• Dennis Thompson HealthDay Reporter
• December 12, 2025
• Full Page

FRIDAY, Dec. 12, 2025 (HealthDay News) — More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment, clinical trial results show.

Ianalumab, a monoclonal antibody, helped patients with im...